Health
Johnson & Johnson starts human study of COVID-19 vaccine after promising monkey data – Reuters India
Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
(Reuters) – Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in nasal swabs, according to the study p…
-
General15 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News17 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
Business20 hours agoThese ASX 200 shares could rise 55% to 65%
-
Noosa News22 hours agoBarn-owl project reducing farmers’ reliance on poison to manage rats and mice